BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8574739)

  • 41. Clarithromycin dual therapy regimens for eradication of Helicobacter pylori: a review.
    Pipkin GA; Dixon JS; Williamson R; Wood JR
    Helicobacter; 1997 Dec; 2(4):159-71. PubMed ID: 9421117
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial.
    Feng LY; Yao XX; Jiang SL
    World J Gastroenterol; 2005 Feb; 11(7):1083-6. PubMed ID: 15742421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori.
    Sieg A; Sellinger M; Schlauch D; Hörner M; Fuchs W
    Aliment Pharmacol Ther; 1999 Jul; 13(7):865-8. PubMed ID: 10383519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of clarithromycin in Helicobacter pylori eradication therapy in patients with liver cirrhosis.
    Azuma T; Ito S; Suto H; Ito Y; Miyaji H; Yamazaki Y; Kato T; Kuriyama M
    Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():216-22. PubMed ID: 10807427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial.
    Schwizer W; Thumshirn M; Dent J; Guldenschuh I; Menne D; Cathomas G; Fried M
    Lancet; 2001 Jun; 357(9270):1738-42. PubMed ID: 11403809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination therapy with clarithromycin and sofalcone for eradication of Helicobacter pylori.
    Kodama R; Fujioka T; Fujiyama K; Kawasaki H; Kubota T; Nasu M
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S125-8. PubMed ID: 7735929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Helicobacter pylori eradication and peptic ulcer healing: the impact of deleting the proton pump inhibitor and using a once-daily treatment.
    Wheeldon TU; Hoang TT; Phung DC; Björkman A; Granström M; Sörberg M
    Aliment Pharmacol Ther; 2003 Jul; 18(1):93-100. PubMed ID: 12848630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children.
    Kato S; Takeyama J; Ebina K; Naganuma H
    Pediatrics; 1997 Jul; 100(1):E3. PubMed ID: 9200377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori.
    Fennerty MB; Kovacs TO; Krause R; Haber M; Weissfeld A; Siepman N; Rose P
    Arch Intern Med; 1998 Aug 10-24; 158(15):1651-6. PubMed ID: 9701099
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection.
    Shashidhar H; Peters J; Lin CH; Rabah R; Thomas R; Tolia V
    J Pediatr Gastroenterol Nutr; 2000 Mar; 30(3):276-82. PubMed ID: 10749411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proton pump inhibitors for Helicobacter pylori eradication in patients with peptic ulcer.
    Yamamoto I; Fukuda Y; Okui M; Tamura K; Shimoyama T
    J Clin Gastroenterol; 1995; 20 Suppl 1():S38-42. PubMed ID: 7673613
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy.
    Lindsetmo RO; Johnsen R; Revhaug A
    Scand J Gastroenterol; 1998 Mar; 33(3):231-5. PubMed ID: 9548613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment].
    Tokushima H; Tamura H; Matsumura O; Murakawa M; Itakura Y; Itoyama S; Mitarai T; Isoda K
    Nihon Jinzo Gakkai Shi; 1996 Aug; 38(8):349-55. PubMed ID: 8828354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trial.
    Lai KC; Lam SK; Chu KM; Hui WM; Kwok KF; Wong BC; Hu HC; Wong WM; Chan OO; Chan CK
    Aliment Pharmacol Ther; 2003 Oct; 18(8):829-36. PubMed ID: 14535877
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Efficacy of the dosing regimen of pantoprazole 40 mg, amoxicillin 1000 mg and clarithromycin 500 mg, twice daily for 7 days, in the eradication of Helicobacter pylori in patients with peptic ulcer].
    Coelho LG; Mattos AA; Francisconi CF; Castro Lde P; André SB
    Arq Gastroenterol; 2004; 41(1):71-6. PubMed ID: 15499429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of seven and fourteen days of lansoprazole, clarithromycin, and amoxicillin therapy for eradication of Helicobacter pylori: a report from India.
    Bhasin DK; Sharma BC; Ray P; Pathak CM; Singh K
    Helicobacter; 2000 Jun; 5(2):84-7. PubMed ID: 10849056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treating Helicobacter pylori.
    Howden CW; Hunt RH
    Arch Intern Med; 1998 Nov; 158(21):2396-8. PubMed ID: 9827792
    [No Abstract]   [Full Text] [Related]  

  • 58. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
    Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor, tinidazole and clarithromycin, in Brazilian patients with peptic ulcer.
    Silva FM; Zaterka S; Eisig JN; Chehter EZ; Chinzon D; Laudanna AA
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(1):11-6. PubMed ID: 11378678
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Eradication of Helicobacter pylori with lansoprazole and clarithromycin.
    Harris AW; Gummett PA; Logan RP; Ashworth HM; Baron JH; Misiewicz JJ
    Aliment Pharmacol Ther; 1995 Apr; 9(2):201-4. PubMed ID: 7605863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.